EUVIMEDEUVIMED entdecken
Crossref

Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients

Danielle Morris, B. Tate Cutshall, Haley Watson, Elizabeth Wolfe, Leia Wentzler-Lara, Drew A. Wells

SN Comprehensive Clinical Medicine · 06.10.2026 · 8 (1)

DOI: 10.1007/s42399-026-02738-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 06.10.2026. Verfasst von Danielle Morris und 5 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Morris, D., Cutshall, B. T., Watson, H., Wolfe, E., Wentzler-Lara, L., & Wells, D. A. (2026). Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02738-5

Vancouver

Morris D, Cutshall BT, Watson H, Wolfe E, Wentzler-Lara L, Wells DA. Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02738-5

BibTeX
@article{Morris2026,
  author = {Morris, Danielle and Cutshall, B. Tate and Watson, Haley and Wolfe, Elizabeth and Wentzler-Lara, Leia and Wells, Drew A.},
  title = {Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients},
  journal = {SN Comprehensive Clinical Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1007/s42399-026-02738-5}
}
Kostenlos starten →